APA (7th ed.) Citation

Vahedpour, Z., Boroumand, H., Tabatabaee Anaraki, S., Tabasi, Z., Motedayyen, H., Akbari, H., . . . Ostadmohammadi, V. (2022). Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial. International journal of clinical practice (Esher), 2022(1), 1263544. https://doi.org/10.1155/2022/1263544

Chicago Style (17th ed.) Citation

Vahedpour, Zahra, Homa Boroumand, Shirin Tabatabaee Anaraki, Zohre Tabasi, Hossein Motedayyen, Hossein Akbari, Fariba Raygan, and Vahidreza Ostadmohammadi. "Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial." International Journal of Clinical Practice (Esher) 2022, no. 1 (2022): 1263544. https://doi.org/10.1155/2022/1263544.

MLA (9th ed.) Citation

Vahedpour, Zahra, et al. "Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial." International Journal of Clinical Practice (Esher), vol. 2022, no. 1, 2022, p. 1263544, https://doi.org/10.1155/2022/1263544.